Form 4: Select Medical Director Receives Restricted Stock Grant

Select Medical Holdings Corporation director Katherine R. Davisson was granted 14,035 shares of restricted common stock, vesting on July 29, 2026.

Summary

• Katherine R. Davisson, a Director of Select Medical Holdings Corporation (SEM), was granted 14,035 shares of common stock.
• The transaction date for this acquisition was July 29, 2025.
• The shares were acquired at a price of $0, indicating a grant rather than a purchase.
• Following this transaction, Ms. Davisson beneficially owns 60,035 shares of common stock directly.
• The granted restricted stock is subject to certain exceptions and will vest in full on July 29, 2026, which is the first anniversary of the grant date.

Sentiment

Score: 7

Explanation: The filing indicates a routine equity compensation event for a director, which is generally positive for aligning interests but not a significant market-moving event. It reflects standard corporate governance.

Positives

• Grant of restricted stock aligns the director's interests with shareholders, as the value of the compensation is tied to the company's stock performance.
• The vesting schedule encourages long-term commitment from the director.

Future Outlook

The restricted stock grant is structured to vest on July 29, 2026, indicating a future milestone for the director's equity compensation.

Industry Context

This restricted stock grant is a common form of equity compensation for directors in publicly traded companies across various industries, designed to align their interests with long-term shareholder value creation. It reflects standard corporate governance practices for executive and director remuneration.

Comparison to Industry Standards

• The grant of restricted stock at a $0 price is a standard method for compensating directors, similar to practices at comparable healthcare providers or companies of similar market capitalization.
• The one-year vesting period is a common structure for director equity awards, aiming to retain talent and incentivize performance over a defined period, consistent with benchmarks seen in companies like HCA Healthcare or Universal Health Services for their non-executive directors.

Corporate Governance

Related Party Transactions

• The grant of restricted stock to Katherine R. Davisson, a director, constitutes a transaction with a related party as part of her compensation.

Stakeholder Impact

• Shareholders: The grant aligns the director's financial interests with the company's stock performance, potentially benefiting shareholders through improved governance and strategic decisions.
• Employees: No direct impact on general employees is indicated by this specific filing.

Next Steps

• The restricted stock grant is scheduled to vest in full on July 29, 2026.

Key Dates

Recommendation

This Form 4 filing details a routine restricted stock grant to a director, which is a standard component of executive compensation designed to align interests. It does not present new information that would fundamentally alter the investment thesis for Select Medical Holdings Corporation, nor does it indicate significant positive or negative operational or financial developments. Therefore, a 'hold' recommendation is appropriate as this event is expected and does not warrant a change in investment posture based solely on this filing.

Keywords

Select Medical Holdings Corporation, SEM, Form 4, Restricted Stock, Stock Grant, Director Compensation, Insider Transaction, Equity Compensation